ARCHIVES

Telatinib Demonstrates Positive Results in First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Advocacy Groups Form Council To Lobby For Cancer Programs To Benefit Minorities

April 28, 1995

NCI RFA Available: Minority-Based CCOPS

August 15, 1997

Wynder, Doll, Hill Share Ochsner Award

September 23, 1988

CIS Celebrates 15th Anniversary, Praised By M. Quayle

December 6, 1991

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

NTP Plans Look At Radiation, Viruses, In Carcinogen Report.

July 27, 2001